chr1-1046519-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198576.4(AGRN):c.3034G>A(p.Ala1012Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000399 in 1,602,004 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_198576.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGRN | NM_198576.4 | c.3034G>A | p.Ala1012Thr | missense_variant | 18/36 | ENST00000379370.7 | NP_940978.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGRN | ENST00000379370.7 | c.3034G>A | p.Ala1012Thr | missense_variant | 18/36 | 1 | NM_198576.4 | ENSP00000368678 | P1 | |
AGRN | ENST00000651234.1 | c.2719G>A | p.Ala907Thr | missense_variant | 17/38 | ENSP00000499046 | ||||
AGRN | ENST00000652369.1 | c.2719G>A | p.Ala907Thr | missense_variant | 17/35 | ENSP00000498543 | ||||
AGRN | ENST00000620552.4 | c.2620G>A | p.Ala874Thr | missense_variant | 18/39 | 5 | ENSP00000484607 |
Frequencies
GnomAD3 genomes AF: 0.0000794 AC: 12AN: 151042Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000531 AC: 13AN: 244862Hom.: 0 AF XY: 0.0000749 AC XY: 10AN XY: 133532
GnomAD4 exome AF: 0.0000358 AC: 52AN: 1450840Hom.: 1 Cov.: 54 AF XY: 0.0000346 AC XY: 25AN XY: 722190
GnomAD4 genome AF: 0.0000794 AC: 12AN: 151164Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 73888
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 8 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 08, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1012 of the AGRN protein (p.Ala1012Thr). This variant is present in population databases (rs144781935, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with AGRN-related conditions. ClinVar contains an entry for this variant (Variation ID: 570635). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.3034G>A (p.A1012T) alteration is located in exon 18 (coding exon 18) of the AGRN gene. This alteration results from a G to A substitution at nucleotide position 3034, causing the alanine (A) at amino acid position 1012 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at